Skip to content

Gross Profit at other companies

Neogen logo
NeogenNEOG
$99M-10.2%
Zoetis logo
ZoetisZTS
$1.62B+2.6%
Danaher logo
DanaherDHR
$3.59B+2.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Agilent Technologies logo
Agilent TechnologiesA
$990M+14.3%
Quest Diagnostics logo
Quest DiagnosticsDGX

Segments

By segment

See full
CAG$667.51M+16.1%
Water segment revenue$36.54M+13.9%
LPD$16.91M+17.7%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$43.78B+2.0%
Enterprise value$44.15B+1.7%
P/E40×-3.6×
P/S9.9×-0.8×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Calculated from Idexx Laboratories’s reported figures.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's gross profit?
Idexx Laboratories (IDXX) reported gross profit of $722.74M in Q1 2026.
How has Idexx Laboratories's gross profit changed year-over-year?
Idexx Laboratories's gross profit increased by 15.9% year-over-year, from $623.38M to $722.74M.
What is the long-term trend for Idexx Laboratories's gross profit?
Over 4 years (2021 to 2025), Idexx Laboratories's gross profit has grown at a 8.9% compound annual growth rate (CAGR), from $1.89B to $2.66B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.